ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for December 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 27 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 63.50 | 83,333 | 5,291,646 | 1,805,237 | 1.9 M to 1.8 M (-4.41 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 68.18 | 3,393 | 231,335 | 1,888,570 | 1.9 M to 1.9 M (-0.18 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 67.30 | 25,412 | 1,710,228 | 1,891,963 | 1.9 M to 1.9 M (-1.33 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 66.47 | 45,577 | 3,029,503 | 1,917,375 | 2 M to 1.9 M (-2.32 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 65.85 | 8,951 | 589,423 | 1,962,952 | 2 M to 2 M (-0.45 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 69.41 | 8,379 | 581,586 | 1,971,903 | 2 M to 2 M (-0.42 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 68.51 | 10,343 | 708,599 | 1,980,282 | 2 M to 2 M (-0.52 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 67.31 | 58,059 | 3,907,951 | 1,990,625 | 2 M to 2 M (-2.83 %) |
Dec 13 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 66.82 | 23,219 | 1,551,494 | 2,048,684 | 2.1 M to 2 M (-1.12 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 62.00 | 8,022 | 497,364 | 2,071,903 | 2.1 M to 2.1 M (-0.39 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 60.73 | 4,011 | 243,588 | 2,079,925 | 2.1 M to 2.1 M (-0.19 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 72.95 | 3,656 | 266,705 | 2,083,936 | 2.1 M to 2.1 M (-0.18 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 72.13 | 3,800 | 274,094 | 2,087,592 | 2.1 M to 2.1 M (-0.18 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 70.72 | 2,448 | 173,123 | 2,091,392 | 2.1 M to 2.1 M (-0.12 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 69.50 | 6,617 | 459,882 | 2,093,840 | 2.1 M to 2.1 M (-0.32 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 68.50 | 8,510 | 582,935 | 2,100,457 | 2.1 M to 2.1 M (-0.40 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 67.63 | 7,193 | 486,463 | 2,108,967 | 2.1 M to 2.1 M (-0.34 %) |
Dec 04 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 66.58 | 5,743 | 382,369 | 2,116,160 | 2.1 M to 2.1 M (-0.27 %) |